HUB Investment Partners’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$151K Buy
600
+100
+20% +$21.5K ﹤0.01% 1242
2026
Q1
$109K Hold
500
﹤0.01% 1055
2025
Q4
$114K Hold
500
﹤0.01% 892
2025
Q3
$116K Hold
500
﹤0.01% 745
2025
Q2
$92.8K Buy
+500
New +$92.9K ﹤0.01% 681

Other funds holding ABBV

HUB Investment Partners's ABBV Position: Q2 2026 in Review

HUB Investment Partners increased its AbbVie (ABBV) stake by 36% in Q2 2026, buying an estimated $8.95M and bringing the position to 158,806 shares worth $40M. The position accounts for 0.72% of the portfolio, ranked #25.

HUB Investment Partners first reported a position in ABBV in Q4 2020 and has held it in 23 quarters since. 2,440 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • HUB Investment Partners held 158,806 shares of AbbVie worth $40M as of Q2 2026.
  • HUB Investment Partners bought 41,607 AbbVie shares in Q2 2026, an estimated $8.95M.
  • AbbVie made up 0.72% of HUB Investment Partners's portfolio in Q2 2026, its #25 holding.
  • HUB Investment Partners first reported a position in AbbVie in Q4 2020 and has held it in 23 quarters since.
  • 2,440 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on HUB Investment Partners's 13F filing for Q2 2026, filed 31 Jul 2026.